...
首页> 外文期刊>Viral immunology >DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
【24h】

DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.

机译:DNA引发的E和NS1构建体-同源蛋白增强了免疫策略,以改善小鼠抗登革热的免疫反应。

获取原文
获取原文并翻译 | 示例
           

摘要

DNA priming-protein boosting is a strategy used to establish strong immunity to a specific pathogen by the use of two different antigens through sequential delivery systems. In this work, two recombinant plasmids were used, one encoding for the dengue virus E protein, which is know to induce neutralizing antibodies (pcDNA 3.1/E), and the other encoding for the Dengue virus nonstructural protein 1 (pcDNA 3.1/NS1), as a source of B- and T-cell epitopes possibly involved in protective immunity. We showed that immunization of BALB/c mice with three priming doses of both plasmids pcDNA 3.1/E and/or pcDNA 3.1/NS1 were able to induce antibody responses to E protein with a single plasmid; in contrast to the antibody response to NS1 protein we observed an additive effect in terms of antibody response. Moreover, using a prime-boost protocol in which both plasmid constructs were co-administrated followed by a boost of homologous GST-E and GST-NS1 recombinant proteins, we observed an increased antibody response toNS1 and to E protein compared to animals vaccinated with the proteins or with dengue constructs alone. If neutralizing antibodies play an important role in dengue infection, antibodies generated with this regimen was also significantly better than the administration of the mix of proteins alone. These results suggest that NS1 and E proteins together could be considered in a design of subunit recombinant vaccines.
机译:DNA引发蛋白增强是一种通过顺序递送系统通过使用两种不同抗原来建立对特定病原体的强免疫力的策略。在这项工作中,使用了两个重组质粒,一个编码登革热病毒E蛋白,已知能诱导中和抗体(pcDNA 3.1 / E),另一个编码登革热病毒非结构蛋白1(pcDNA 3.1 / NS1)。作为可能参与保护性免疫的B细胞和T细胞表位的来源。我们显示,用三种引发剂量的质粒pcDNA 3.1 / E和/或pcDNA 3.1 / NS1免疫BALB / c小鼠,能够通过单个质粒诱导对E蛋白的抗体反应。与针对NS1蛋白的抗体反应相反,我们在抗体反应方面观察到了加和效应。此外,使用初免-加强方案,其中两种质粒构建体均共同施用,然后加强同源的GST-E和GST-NS1重组蛋白,我们观察到与接种了GST-E和GST-NS1疫苗的动物相比,对NS1和E蛋白的抗体反应增加。蛋白质或单独使用登革热构建体。如果中和抗体在登革热感染中起重要作用,则用这种方案产生的抗体也明显优于单独施用蛋白质混合物。这些结果表明,NS1和E蛋白可以一起设计亚单位重组疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号